Apr. 24 2023
Source Page: Non-technical summaries granted in 2022Found: We are constantly looking for minimally invasive ways of collecting samples or data.
Asked by: George Howarth (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has taken recent steps with NHS England to help support NHS trusts to make contractual arrangements for minimally invasive cancer therapies.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
NHS England commissions selective internal radiation therapy (SIRT) as a treatment choice for patients with unresectable advanced hepatocellular carcinoma (HCC), in accordance with Technology Appraisal 688 and metastatic colorectal cancer (mCRC), in accordance with an NHS England clinical commissioning policy.
In total, following regional completion of contractual negotiations and changes, we expect that there will be 19 providers of SIRT in the National Health Service in England. Nine will offer SIRT as a treatment for both HCC and mCRC, a further nine will offer SIRT as a treatment for HCC only and a single provider will offer SIRT as a treatment for mCRC.
Mar. 03 2023
Source Page: Non-technical summaries granted in 2021Found: CSF is obtained via a quick, minimally invasive surgical procedure under general anaesthetic so that
Feb. 16 2023
Source Page: A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-CoV-2 RNA vaccine candidates against COVID-19 in healthy individuals. (3 docs).Found: In addition, with the currently available therapies for the irtreatment, many individuals with chronic
Increasing the access to minimally invasive cancer therapies is the last topic of today’s #LordsQs in a question from Lord Aberdare. 📺 Watch online from 3.05pm https://t.co/cszlVQNMfw 4/4 https://t.co/crJnX137d2
Mentions:
1: Lord Aberdare (CB - Excepted Hereditary) invasive cancer therapies. - Speech Link
2: Lord Evans of Rainow (CON - Life peer) invasive cancer therapies. - Speech Link
3: Lord Allan of Hallam (LDEM - Life peer) invasive cancer therapies. - Speech Link
4: Lord Evans of Rainow (CON - Life peer) invasive cancer therapies. - Speech Link
5: Lord Aberdare (CB - Excepted Hereditary) invasive cancer therapies. - Speech Link
Asked by: Greg Smith (Conservative - Buckingham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is making to ensure there is sufficient infrastructure in Cancer Alliances to help deliver minimally invasive cancer therapies across England.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
NHS England’s specialised commissioning team have been undertaking work to expand the number of providers offering minimally invasive cancer therapies, such as selective internal radiation therapy.
The market engagement and Prior Information Notices have now been completed, with regional teams now putting in place the necessary contractual arrangements with National Health Service trusts. This work is also being completed ahead of the delegation of commissioning responsibilities to integrated care boards.
Oct. 12 2022
Source Page: Private healthcare market investigationFound: In addition, the Agreement extended the referral obligations to invasive and non -invasive cardiology
Oct. 12 2022
Source Page: Private healthcare market investigationFound: Oncology The agreed maxima for the supervision of chemotherapy and other supportive therapies have